Yes, one cannabis compound is a proven epilepsy treatment: purified cannabidiol (CBD), sold as the prescription drug Epidiolex, is FDA-approved for seizures caused by Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex in patients 1 year and older. For other kinds of epilepsy, and for THC-rich marijuana or store-bought CBD, the evidence is still weak. Nobody should stop or change seizure medication without their neurologist.
Epilepsy is the medical condition that turned cannabis research from anecdote into hard science. For decades the case rested on animal studies and a handful of tiny human trials. That changed between 2017 and 2021, when large, placebo-controlled trials of pharmaceutical CBD were published in the New England Journal of Medicine, The Lancet and JAMA Neurology. This guide explains what those studies showed, what they did not show, and where marijuana from a dispensary fits in. For a trial-by-trial look at the CBD data, see our companion piece on the Epidiolex clinical trial evidence.
Cannabis and Epilepsy: Evidence at a Glance
| Claim | Evidence level | Source |
|---|---|---|
| Prescription CBD (Epidiolex) reduces seizures in Lennox-Gastaut and Dravet syndromes | Strong (several phase 3 randomized trials, FDA approval) | NEJM 2017, NEJM 2018 |
| Prescription CBD reduces seizures in tuberous sclerosis complex | Strong (one large phase 3 trial, FDA approval) | JAMA Neurology 2021 |
| CBD helps other forms of epilepsy, including common focal epilepsy in adults | Insufficient | NCCIH |
| THC or whole-plant marijuana controls seizures | Insufficient (case reports and surveys only) | National Academies 2017 |
| Over-the-counter CBD products contain what the label says | Often not | JAMA 2017 |
What the Early Studies Found
Interest in cannabis for seizures goes back more than a century, but the modern story starts in 1980. A Brazilian team that included Raphael Mechoulam, the chemist who first identified THC, gave 200 to 300 mg of CBD a day or placebo to 15 people whose epilepsy was no longer controlled by their usual drugs. Of the 8 on CBD, 4 became almost free of convulsions and 3 improved partly; 1 of the placebo patients improved. The study, published in Pharmacology, was far too small to prove anything and is best read as an early signal.
That signal sat largely untested for more than 30 years. When Cochrane reviewers looked at the evidence in 2014, they found four small randomized reports covering 48 patients, all of low quality, and concluded that no reliable conclusions could be drawn about whether cannabinoids work for epilepsy. The National Academies of Sciences reached a similar verdict in its 2017 report, rating the evidence for cannabinoids in epilepsy as insufficient. That report went to press just as the first big CBD trials were being published, so it is now out of date on this point.
The Trials That Changed the Picture
Pressure from families of children with severe epilepsy, many of whom had tried artisanal CBD oils, pushed researchers to run proper trials. A 2016 open-label study in The Lancet Neurology gave pharmaceutical CBD to 214 children and young adults with treatment-resistant epilepsy. Among those with efficacy data, the median reduction in monthly motor seizures was 36.5%. Open-label studies have no placebo group, so the result could not prove CBD caused the drop.
Randomized, double-blind trials followed:
- Dravet syndrome (2017): 120 children and young adults. Median convulsive seizures fell from 12.4 to 5.9 a month on CBD, versus 14.9 to 14.1 on placebo.
- Lennox-Gastaut syndrome (2018, two trials): drop seizures fell by a median of roughly 37% to 44% on CBD, versus about 17% to 22% on placebo.
- Tuberous sclerosis complex (2021): 224 patients. Seizures fell about 48% on CBD versus 27% on placebo.
These results led the FDA to approve Epidiolex in 2018 for Lennox-Gastaut and Dravet syndromes, then in 2020 to add tuberous sclerosis complex and lower the minimum age to 1 year. The current Epidiolex label lists all three conditions. The full trial details, including doses and side-effect rates, are broken down in our Epidiolex research article.
What CBD Does Not Do
The approved uses are narrow, and that matters. Lennox-Gastaut, Dravet and tuberous sclerosis complex are rare, severe conditions that usually begin in childhood. Most people with epilepsy have other forms, especially focal epilepsy, and the National Center for Complementary and Integrative Health notes that research on more common types is not yet sufficient to draw conclusions.
Even in the approved conditions, CBD is an add-on, not a replacement. In the trials, every patient stayed on their existing seizure medicines. Few became seizure-free: in the Dravet trial, 5% of the CBD group had no convulsive seizures during treatment. The realistic goal is fewer seizures, not a cure.
Is Marijuana or Store-Bought CBD the Same as Epidiolex?
No, and the differences are practical, not just legal.
| Epidiolex | Dispensary or hemp CBD | |
|---|---|---|
| Purity and dose | Purified CBD at a known concentration, dosed by body weight | Varies by product and batch; labels often inaccurate |
| THC content | Essentially none | May contain THC, sometimes more than listed |
| Tested in seizure trials | Yes, phase 3 | No |
| Doctor monitoring | Liver tests before and during treatment | Usually none |
| Insurance coverage | Often covered with prior authorization | Not covered |
A 2017 analysis in JAMA tested 84 CBD products sold online and found that most were mislabeled for CBD content, and some contained THC that was not on the label (Bonn-Miller et al.). The trial doses of Epidiolex, 10 to 25 mg per kilogram per day, are also far higher than what most retail CBD users take. A 20 kg child at 20 mg/kg needs 400 mg of CBD a day, which is impractical and unreliable with consumer products.
THC is a separate question. Some patients and parents report fewer seizures with THC-containing products, but there are no controlled trials showing benefit, and THC brings intoxication, cognitive effects and, in some people, anxiety. There is also no good evidence that a specific strain helps, despite how many products are marketed that way.
Risks and Side Effects
CBD is not harmless just because it does not cause a high. According to the Epidiolex prescribing information:
- Liver injury: CBD can raise liver enzymes. The risk is highest in people also taking valproate, and somewhat higher with clobazam. Doctors check liver tests before and during treatment.
- Drowsiness and sedation: among the most common effects.
- Other common effects: decreased appetite, diarrhea, fatigue, rash, sleep problems and infections.
- Suicidal thoughts: like other seizure drugs, it carries a warning to watch for mood changes.
- Do not stop suddenly: abrupt withdrawal of any seizure medicine can trigger more seizures or status epilepticus.
CBD also interacts with other drugs, which is one more reason to involve the prescribing neurologist before adding any cannabis product. The FDA’s CBD guidance covers the risks of unapproved products.
Legal Status
Epidiolex is a prescription drug available in all 50 states, and the label states it is not a controlled substance. Marijuana and THC products remain federally illegal outside state programs; our federal cannabis law guide explains the current status. Rules for medical and adult-use cannabis vary by state; see the Washington and Oregon guides, or the full list on our cannabis laws page.
Talk to Your Doctor
If you or your child has drug-resistant seizures, ask a neurologist or epileptologist whether the diagnosis fits an Epidiolex indication, whether off-label use makes sense, and how it would interact with current medicines. Bring a list of any CBD or cannabis products already in use, including doses. Keep a seizure diary before and after any change so the effect can be judged on data rather than impressions. Never cut back other seizure drugs on your own.
Cannabis and Epilepsy FAQ
Does CBD stop seizures?
Prescription CBD reduces seizures in Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex, typically cutting seizure frequency by about 40% to 50% in trials. It rarely stops them completely, and it is used alongside other seizure medicines.
Is Epidiolex just CBD oil?
It is a purified, pharmaceutical-grade CBD oral solution made to strict manufacturing standards. Retail CBD oils are not tested the same way and often do not match their labels, so they are not interchangeable.
Can THC help epilepsy?
There is no good controlled evidence that THC reduces seizures. Reports are anecdotal, and THC adds intoxication and other side effects.
Can adults with epilepsy take Epidiolex?
Yes, if they have one of the approved conditions; the label covers patients 1 year and older. For other types of epilepsy, any use would be off-label and is a decision for a neurologist.
Can cannabis make seizures worse?
It can in some cases. Products of unknown strength, drug interactions and stopping prescribed medicines can all raise seizure risk. That is why changes should be made under medical supervision.
More on the science of cannabis and health is in our cannabis research section.
For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.